Free Trial

Short Interest in Omron Corp. (OTCMKTS:OMRNY) Drops By 48.6%

Omron logo with Computer and Technology background

Key Points

  • Short interest in Omron Corp. decreased by 48.6%, dropping from 21,000 shares to 10,800 shares as of September 15th.
  • Institutional investor GAMMA Investing LLC increased its position in Omron by an impressive 831.8%, acquiring an additional 13,342 shares during the first quarter.
  • Omron's stock price opened at $28.88, showing a 4.3% increase, with a market cap of $5.96 billion and earnings per share of $0.24 for the last quarter.
  • Five stocks to consider instead of Omron.

Omron Corp. (OTCMKTS:OMRNY - Get Free Report) was the target of a large decrease in short interest in September. As of September 15th, there was short interest totaling 10,800 shares, a decrease of 48.6% from the August 31st total of 21,000 shares. Based on an average trading volume of 81,300 shares, the short-interest ratio is currently 0.1 days. Based on an average trading volume of 81,300 shares, the short-interest ratio is currently 0.1 days.

Institutional Trading of Omron

An institutional investor recently raised its position in Omron stock. GAMMA Investing LLC grew its position in Omron Corp. (OTCMKTS:OMRNY - Free Report) by 831.8% during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 14,946 shares of the company's stock after acquiring an additional 13,342 shares during the quarter. GAMMA Investing LLC's holdings in Omron were worth $421,000 at the end of the most recent reporting period. Hedge funds and other institutional investors own 1.09% of the company's stock.

Omron Trading Up 4.3%

OMRNY stock opened at $28.88 on Friday. The firm has a fifty day moving average price of $26.59 and a 200 day moving average price of $27.15. Omron has a fifty-two week low of $24.16 and a fifty-two week high of $46.31. The firm has a market cap of $5.96 billion, a PE ratio of 26.02, a price-to-earnings-growth ratio of 0.39 and a beta of 1.10. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.54 and a current ratio of 2.34.

Omron (OTCMKTS:OMRNY - Get Free Report) last released its quarterly earnings data on Wednesday, August 6th. The company reported $0.24 EPS for the quarter, beating the consensus estimate of $0.19 by $0.05. Omron had a net margin of 4.04% and a return on equity of 3.46%. The business had revenue of $1.29 billion during the quarter, compared to analyst estimates of $1.31 billion. Sell-side analysts anticipate that Omron will post 0.42 earnings per share for the current fiscal year.

About Omron

(Get Free Report)

OMRON Corporation engages in industrial automation, device and module solutions, social systems, and healthcare businesses worldwide. The Industrial Automation Business offers sensors, switches, safety and control components, relays, motion and drives, robotics, energy conservation, power supplies, and automation system products.

Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Omron Right Now?

Before you consider Omron, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Omron wasn't on the list.

While Omron currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.